News Archives - Page 2 of 795

ThursdayJul 02, 2026 9:00 am

CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) Implementing Plan to Assess Underground Resource and Exploit Above-Ground Stockpile at Clayton Property in Idaho

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising. CMX’s Clayton Silver Project in Idaho is a historic mine that produced silver, zinc, copper, lead, and gold between 1935 and 1986 Due to the small scale of mining operations, the Clayton ore bodies were never fully mined, while mined material at grades considered too low was left unprocessed, creating a stockpile The stockpile and the unexplored mine represent significant exploitation potential for the company CMX plans to install an ore-sorting system on site to process the stockpile, which potentially holds 1,000,000…

WednesdayJul 01, 2026 12:00 pm

The Next Battle in Space Isn’t Launching Satellites. It’s Managing Them.

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising. SpaceX's record June 2026 IPO put a public spotlight on space, yet most of the sector's frontier companies remain private and out of reach for public investors Antaris, a software-defined space infrastructure company backed by Planet Ventures, signed a memorandum of agreement with Transcelestial to develop and flight-test a combined surveillance and optical-communications architecture on its JANUS-2 mission in late 2026 Planet Ventures gives public-market investors exposure to private space companies such as Antaris, Relativity Space, and General Astronautics that are typically accessible only…

WednesdayJul 01, 2026 11:15 am

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Advances Santa Fe, Walker Lane amid Tightening Gold Supply Dynamics

Disseminated on behalf of  Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising. Top gold-producing countries are showing strain of widespread government, cost and environmental pressures. These pressures strengthen the case for secure, transparent and infrastructure-supported gold development in the United States. Existing mine infrastructure, historical production, oxide material and location in a leading U.S. gold state may give Lahontan’s Santa Fe project a different development profile. Global gold supply is entering a more complicated era, shaped not only by geology and discovery rates but also by government policy, rising operating costs, safety enforcement, environmental oversight and growing…

WednesdayJul 01, 2026 10:30 am

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Delivers First Edge AI Intoxication Detection Kiosk Prototypes

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio kiosks use artificial intelligence and voice analysis to detect potential intoxication and fatigue in workplace environments. The company is targeting industries such as mining, aviation, construction, transportation, and law enforcement, where safety-sensitive operations require large-scale screening. MindBio’s AI models have been trained on more than 50 million data points and analyze over 140 acoustic markers associated with impairment. Prototype kiosks are entering testing, validation, and data-analysis phases, before broader commercial deployment. The company is positioning this important new technology as a faster and…

WednesdayJul 01, 2026 9:45 am

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Showcases Unique MS Drug Candidate, Growth Strategy During Executive Podcast

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma executive co-chairman and co-founder Anthony Durkacz appeared as a guest on the BioMedWire Podcast. Durkacz outlined the company’s strategy for advancing Lucid-MS, the company’s lead drug candidate for multiple sclerosis. The Quantum BioPharma exec also provided an update on unbuzzd, the company’s innovative, clinically validated alcohol metabolism accelerator designed to help sober people up faster. Executive thought leadership has become an increasingly important component of corporate communications, particularly in highly specialized industries such as biotechnology. Through podcasts, interviews and other educational forums,…

WednesdayJul 01, 2026 9:00 am

Rare Earths in 2026: Structural Deficits Open Ground for Junior Developers Like Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF)

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising. The global rare earth elements market is projected to grow from roughly $14 billion in 2025 to more than $41 billion by 2034, driven by accelerating demand from EV traction motors, wind turbines, consumer electronics, and defense applications China continues to dominate rare earth mining and processing capacity, leaving Western manufacturers exposed to persistent supply concentration risk as governments push to build alternative supply chains Canamera Energy Metals raised approximately $10.2 million over four months ending March 2026 and is advancing active exploration…

MondayJun 29, 2026 11:15 am

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Prepares to Produce Gold Amid Inflation’s Upward Pressure on Prices

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising. Consumer prices have risen notably during recent months, linked by many to the United States’ involvement in launching the Iran War and the resulting strictures on international energy transports Gold bullion prices have, with expected variations, enjoyed a significant rise since January of last year, and the precious metal is anticipated to continue acting as a long-term “hedge” or “safe haven” against inflationary pressures Near-term gold producer LaFleur Minerals is preparing to restart its recommissioned Beacon Gold Mill and to draw on mineralized material…

MondayJun 29, 2026 10:30 am

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks

Cardio Diagnostics has positioned the science of epigenetics at the center of its diagnostic platform. Looking at an individual person’s epigenetics can provide invaluable insight into the impact of their lifestyle, behavior, and environment. Epigenetics does more than pinpoint a problem, says CEO; it also provides some level of solution. When most people think about their risk for heart disease, they think about family history. Did a parent or grandparent have a heart attack? Is heart disease “in their genes”? It's an understandable assumption, and genetics does play a role in cardiovascular risk. But a growing body of research suggests…

MondayJun 29, 2026 9:45 am

SS Innovations International Inc. (NASDAQ: SSII) Reports Strong Q1 2026 Results with Surgical Robotics Expansion

SS Innovations reported record first-quarter 2026 revenue of $11.1 million, up 116.8% year over year, driven by growing adoption of its SSi Mantra surgical robotic system. The installed base reached 194 SSi Mantra systems across 11 countries, with nearly 9,750 cumulative robotic procedures completed. Regulatory approvals in Sri Lanka, Kenya, Indonesia, and the Philippines, expanded the company's international market access during the quarter. SS Innovations recently completed the world's longest-distance robotic cardiac telesurgery in history, demonstrating the capabilities of its remote surgery platform. The company continues pursuing regulatory clearance in both the United States and Europe while expanding its presence…

FridayJun 26, 2026 12:00 pm

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease (‘CHD’) Detection

For decades, cardiovascular risk assessment has centered on a checklist of factors never designed to capture the full biological picture of how heart disease develops. What makes CHD numbers particularly troubling is that so much of this is preventable. Cardio Diagnostics has developed clinical tests rooted in epigenetics and genetics fields that examine how genes are expressed and regulated at the molecular level. Coronary heart disease (“CHD”) remains the leading cause of death in the United States, but the tools doctors have long relied on to detect it early are proving less reliable than many patients assume. Cardio Diagnostics Holdings…

Site Search

Company Search

Category: News